FeesSafety
Pluang+

IRulya Therapeutics to present at Evercore Healthcare Conference on Nov 30, 2026

Market News
19 Nov 2026, 15:00 WIB
GlobeNewsWire
View Source
Neutral
IRulya Therapeutics to present at Evercore Healthcare Conference on Nov 30, 2026

IRulya Therapeutics Inc., a clinical-stage biopharmaceutical company, announced that its senior management will participate in a fireside chat at the 9th Annual Evercore Healthcare Conference on November 30, 2026. The company is developing LAM-001, a disease-modifying therapy targeting serious pulmonary diseases including pulmonary hypertension associated with interstitial lung disease, bronchiolitis obliterans syndrome, and sarcoidosis-associated pulmonary hypertension. Ongoing Phase 2 clinical trials and an anticipated Phase 2 study later this year highlight IRulya's progress. The event webcast will be available on IRulya's website, offering investors insight into the company's development plans and future outlook.

IRulya Therapeutics is featured as it prepares for the 9th Annual Evercore Healthcare Conference, with Pluang data showing 82 of 150 health-sector US stocks rose while 63 fell as of Nov 19, 2026 19:13 WIB. Notable movers include Sana Biotechnology Inc (SANA) at USD 1.90 with a 1-day change of +2.70% and a typical hold time on Pluang of 27 days, BioNano Genomics Inc (BNGO) at USD 0.95 down 2.65%, and ACADIA Pharmaceuticals Inc. (ACAD) at USD 18.30 up 2.64% with a 100% buy order activity on Pluang.

More News

Bath & Body Works beats earnings and revenue estimates, launches $500M buyback, raises sales outlook.

Bath & Body Works beats earnings and revenue estimates, launches $500M buyback, raises sales outlook.

Bath & Body Works reported third-quarter earnings per share of $0.26, surpassing the $0.12 estimate, and revenue of $1.58 billion, above the $1.55 billion estimate. The company also announced a new $500 million share repurchase program and raised its...

Company Fundamentals
Bullish
52 minutes ago
Pasqal integrates quantum processors natively into Slurm for easier HPC management with NVIDIA support.

Pasqal integrates quantum processors natively into Slurm for easier HPC management with NVIDIA support.

Pasqal has integrated its neutral-atom quantum processors natively into Slurm's Hierarchical Resources (HRES) system, recently expanded by NVIDIA. This allows supercomputing centers to manage quantum processing units (QPUs) alongside CPUs and GPUs mo...

Market News
Bullish
56 minutes ago
SpaceX shifts focus from satellite internet profits to rapid AI growth, trading at a high valuation.

SpaceX shifts focus from satellite internet profits to rapid AI growth, trading at a high valuation.

SpaceX currently earns most of its profits from its Starlink satellite internet service, which has 13.6 million subscribers and generated $2.37 billion in operating income last quarter. However, the company is aggressively pivoting towards artificial...

Market News
Bullish
1 hour ago
TSMC and Applied Materials poised for strong growth amid booming semiconductor demand.

TSMC and Applied Materials poised for strong growth amid booming semiconductor demand.

Despite a recent 25% drop in semiconductor stocks, TSMC and Applied Materials stand out due to their dominant market positions and growth potential. TSMC leads with a 73% share in the foundry market, benefiting from AI chip demand and planned price h...

Market News
Bullish
1 hour ago
Stock market faces sharp correction risk amid AI turmoil and rising interest rates, Buffett advises cautious investing.

Stock market faces sharp correction risk amid AI turmoil and rising interest rates, Buffett advises cautious investing.

The stock market is vulnerable to a sharp correction due to rising interest rates and uncertainty in the AI industry following Nvidia CEO Jensen Huang's departure amid scandal. Inflation pressures have led the Federal Reserve to raise rates, potentia...

Bearish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App